Lidocaine Patches Prior to Percutaneous Nerve Evaluation
Overactive Bladder, Urge Incontinence, Fecal Incontinence
About this trial
This is an interventional treatment trial for Overactive Bladder focused on measuring lidocaine
Eligibility Criteria
Inclusion Criteria: Female patients undergoing sacral neuromodulation to manage their OAB with sacral neuromodulation trial with percutaneous nerve evaluation (PNE) without fluoroscopy. No contraindication to the use of lidocaine patch Age >18 years old Exclusion Criteria: Patients who are not candidates for SNM therapy Patients with contraindications to SNM including pregnancy Allergy to lidocaine or adhesives Chronic pain as an indication for the PNE procedure
Sites / Locations
- ULP Female Pelvic Medicine and Reconstructive Surgery - Springs Medical Center Suite 190Recruiting
- ULP Female Pelvic Medicine and Reconstructive Surgery - Urogynecology Associates officeRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
topical lidocaine patch
Placebo
4% lidocaine patch placed over the sacrum 30 minutes prior to PNE procedure
Adhesive patch placed over the sacrum 30 minutes prior to PNE procedure